Departments of Surgery (Welk), and Epidemiology and Biostatistics (Welk, Killin, Anderson, Garg), Western University; ICES Western (Welk, Killin, Reid, Anderson, Shariff, Garg); Arthur Labatt Family School of Nursing (Shariff) Western University; Department of Medicine (Appleton, Garg), Western University; St. Joseph's Healthcare and London Health Sciences Centre (Kearns), London, Ont.
CMAJ Open. 2021 Nov 30;9(4):E1105-E1113. doi: 10.9778/cmajo.20210071. Print 2021 Oct-Dec.
It is unclear if enhanced electronic medication reconciliation systems can reduce inappropriate medication use and improve patient care. We evaluated trends in potentially inappropriate medication use after hospital discharge before and after adoption of an electronic medication reconciliation system.
We conducted an interrupted time-series analysis in 3 tertiary care hospitals in London, Ontario, using linked health care data (2011-2019). We included patients aged 66 years and older who were discharged from hospital. Starting between Apr. 13 and May 21, 2014, physicians were required to complete an electronic medication reconciliation module for each discharged patient. As a process outcome, we evaluated the proportion of patients who continued to receive a benzodiazepine, antipsychotic or gastric acid suppressant as an outpatient when these medications were first started during the hospital stay. The clinical outcome was a return to hospital within 90 days of discharge with a fall or fracture among patients who received a new benzodiazepine or antipsychotic during their hospital stay. We used segmented linear regression for the analysis.
We identified 15 932 patients with a total of 18 405 hospital discharge episodes. Before the implementation of the electronic medication reconciliation system, 16.3% of patients received a prescription for a benzodiazepine, antipsychotic or gastric acid suppressant after their hospital stay. After implementation, there was a significant and immediate 7.0% absolute decline in this proportion (95% confidence interval [CI] 4.5% to 9.5%). Before implementation, 4.1% of discharged patients who newly received a benzodiazepine or antipsychotic returned to hospital with a fracture or fall within 90 days. After implementation, there was a significant and immediate 2.3% absolute decline in this outcome (95% CI 0.3% to 4.3%).
Implementation of an electronic medication reconciliation system in 3 tertiary care hospitals reduced potentially inappropriate medication use and associated adverse events when patients transitioned back to the community. Enhanced electronic medication reconciliation systems may allow other hospitals to improve patient safety.
目前尚不清楚增强型电子用药核对系统是否能减少不适当的用药并改善患者的护理。我们评估了在采用电子用药核对系统前后出院患者潜在不适当用药的趋势。
我们在安大略省伦敦的 3 家三级保健医院进行了一项中断时间序列分析,使用了链接的医疗保健数据(2011-2019 年)。我们纳入了年龄在 66 岁及以上的出院患者。2014 年 4 月 13 日至 5 月 21 日期间,医生被要求为每个出院患者完成电子用药核对模块。作为一个过程结果,我们评估了在住院期间首次开始使用时,继续作为门诊患者接受苯二氮䓬类、抗精神病药或胃酸抑制剂的患者比例。临床结果是在出院后 90 天内,因跌倒或骨折而返回医院,在住院期间接受新的苯二氮䓬类或抗精神病药的患者。我们使用分段线性回归进行分析。
我们确定了 15932 名患者,共计 18405 例出院。在实施电子用药核对系统之前,16.3%的患者在出院后接受了苯二氮䓬类、抗精神病药或胃酸抑制剂的处方。实施后,这一比例显著且立即下降了 7.0%(95%置信区间 4.5%至 9.5%)。在实施前,4.1%新接受苯二氮䓬类或抗精神病药的出院患者在出院后 90 天内因跌倒或骨折返回医院。实施后,这一结果显著且立即下降了 2.3%(95%置信区间 0.3%至 4.3%)。
在 3 家三级保健医院实施电子用药核对系统,减少了患者回归社区时潜在的不适当用药和相关的不良事件。增强型电子用药核对系统可能使其他医院提高患者的安全性。